ADUS stock gains as Addus HomeCare shows revenue growth and attracts institutional interest
Published on 09/03/2026 at 08:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Addus HomeCare Corporation (ISIN US0067391062) stock has recently traded around the 117 to 118 dollar mark, with a closing price of 118.17 dollars on September 2, 2026, after a 3.0 percent rise that day according to market data compiled by GuruFocus. This places ADUS stock within a 52-week trading range reported by market portals, and positions the company among medical care facilities peers tracked on large financial platforms as of September 2, 2026.
Revenue growth and margin profile in the latest quarter
Recent quantitative research compiled by Argus and shown on a Yahoo Finance report highlights that Addus HomeCare generated revenue of 297.98 million dollars in the second quarter of fiscal year 2026, with earnings of 9.08 million dollars for the same period and a profit margin of 3.05 percent. These Q2 FY26 figures represent a step up from earlier quarters displayed in the same overview, where prior quarters in fiscal 2025 and the first quarter of fiscal 2026 showed lower revenue bars, underlining that quarterly revenue has increased into the high 200 million dollar range by Q2 FY26.
The same Argus-linked quantitative view indicates that consensus estimates for Q2 FY26 earnings per share stood at 0.33 dollars, while the actual EPS delivered by Addus HomeCare reached 0.36 dollars, meaning the company beat the estimate by 0.03 dollars per share in this latest reported quarter. Such a clear, quantified upside versus expectations is a key data point for investors assessing whether ADUS stock’s valuation is supported by operating performance. In addition, the reported 3.05 percent profit margin in Q2 FY26 sits slightly above margins shown for some earlier quarters in the charted history, signaling gradual margin improvement alongside revenue growth.
Institutional activity and valuation signals
On the ownership side, a filing summary reported by MarketBeat notes that Bank of New York Mellon recently held an investment of about 11.22 million dollars in Addus HomeCare Corporation, underscoring ongoing institutional interest in the stock. In the same MarketBeat coverage, ADUS shares were described as opening at 114.55 dollars in a recent session, with a market capitalization stated at approximately 2.14 billion dollars, figures that align with capitalization levels of around 2.19 to 2.20 billion dollars shown on large portals such as Yahoo Finance as of September 2, 2026.
Valuation tools from GuruFocus apply their proprietary GF Value framework to Addus HomeCare and, in a September 2, 2026 article, estimate a fair value of 123.37 dollars for the shares compared with the then-current price of 118.17 dollars. That implies ADUS stock was trading at a 4.2 percent discount to this fair value estimate at that date, an undervaluation signal that some investors may use alongside earnings and margin data. With market data snapshots on Yahoo Finance showing ADUS around 117.39 to 117.84 dollars on September 2, 2026, up roughly 2.5 to 2.9 percent intraday with a market cap just above 2.19 billion dollars, the stock’s price action and valuation picture together form a quantified basis for assessing upside and risk.
Further figures and filings on ADUS stock
Investors who want to follow ADUS stock more closely can find additional quarterly details, ownership filings and valuation data on the dedicated theme page and through the company’s own investor materials.
In-home care services as a demand driver
Addus HomeCare focuses on in-home personal care services, supporting elderly and chronically ill patients with daily living assistance that allows them to remain in their homes rather than moving into institutional facilities. Sector reports on the United States post-acute care market indicate that the broader market was valued at 198.4 billion dollars in 2025 and is projected to reach 287.6 billion dollars by 2033, representing a compound annual growth rate of 5.2 percent over that period. In these market analyses, Addus HomeCare is listed among key players alongside other home health and post-acute providers, underscoring that the company operates in a growing segment with structural demand.
For Addus, the revenue of 297.98 million dollars in Q2 FY26, when set against this expanding market backdrop, suggests that the company is capturing a meaningful slice of the in-home and post-acute care opportunity. Historical references in sector studies show the overall market rising from 198.4 billion dollars in 2025 to the projected 287.6 billion dollars by 2033, and for investors the question is how consistently Addus can grow its share of that total. The company’s ability to slightly expand margins to around 3.05 percent in Q2 FY26 and to modestly beat EPS expectations by 0.03 dollars per share is therefore watched closely as an indicator of execution in a competitive field.
Stock level and investor perspective
From a stock perspective, ADUS has recently traded near 118.17 dollars, with that price as of September 2, 2026 sitting below GF Value’s 123.37 dollar fair value line but within sight of 52-week highs displayed by trading overviews. Market capitalization readings around 2.19 to 2.20 billion dollars place Addus HomeCare in the mid-cap segment of the medical care facilities group, where investors often look for a balance between growth and stability. The combination of Q2 FY26 revenue of 297.98 million dollars, profit margin of 3.05 percent, and an EPS beat of 0.03 dollars per share provides a quantified basis for assessing whether this mid-cap valuation is reasonable.
Institutional interest, as illustrated by the roughly 11.22 million dollar position reported for Bank of New York Mellon, adds another layer to the ADUS stock story. For retail investors, such holdings are not a recommendation but they do signal that professional investors are active in the name, which can support liquidity and coverage. At the same time, valuation tools such as GF Value’s 4.2 percent undervaluation reading remind investors that even after a 3.0 percent price rise on September 2, 2026, ADUS stock is still being modeled as shy of estimated intrinsic value, at least in that framework.
Key data on Addus HomeCare
- Company: Addus HomeCare Corporation
- ISIN: US0067391062
- Ticker: ADUS
- Trading venue: NASDAQ
- Price (as of September 2, 2026): 118.17 USD
- Market capitalization: 2.20 billion USD (as of September 2, 2026)
- Sector / Industry: Medical care facilities / home health
- Index membership: NASDAQ listing, sector peer among US medical care facilities
